• Je něco špatně v tomto záznamu ?

Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus

J. Pokorná, P. Pachl, E. Karlukova, J. Hejdánek, P. Řezáčová, A. Machara, J. Hudlický, J. Konvalinka, M. Kožíšek,

. 2018 ; 10 (7) : . [pub] 20180621

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012595

Neuraminidase is the main target for current influenza drugs. Reduced susceptibility to oseltamivir, the most widely prescribed neuraminidase inhibitor, has been repeatedly reported. The resistance substitutions I223V and S247N, alone or in combination with the major oseltamivir-resistance mutation H275Y, have been observed in 2009 pandemic H1N1 viruses. We overexpressed and purified the ectodomain of wild-type neuraminidase from the A/California/07/2009 (H1N1) influenza virus, as well as variants containing H275Y, I223V, and S247N single mutations and H275Y/I223V and H275Y/S247N double mutations. We performed enzymological and thermodynamic analyses and structurally examined the resistance mechanism. Our results reveal that the I223V or S247N substitution alone confers only a moderate reduction in oseltamivir affinity. In contrast, the major oseltamivir resistance mutation H275Y causes a significant decrease in the enzyme’s ability to bind this drug. Combination of H275Y with an I223V or S247N mutation results in extreme impairment of oseltamivir’s inhibition potency. Our structural analyses revealed that the H275Y substitution has a major effect on the oseltamivir binding pose within the active site while the influence of other studied mutations is much less prominent. Our crystal structures also helped explain the augmenting effect on resistance of combining H275Y with both substitutions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012595
003      
CZ-PrNML
005      
20190408082216.0
007      
ta
008      
190405s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/v10070339 $2 doi
035    __
$a (PubMed)29933553
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pokorná, Jana $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jana.pokorna@uochb.cas.cz.
245    10
$a Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus / $c J. Pokorná, P. Pachl, E. Karlukova, J. Hejdánek, P. Řezáčová, A. Machara, J. Hudlický, J. Konvalinka, M. Kožíšek,
520    9_
$a Neuraminidase is the main target for current influenza drugs. Reduced susceptibility to oseltamivir, the most widely prescribed neuraminidase inhibitor, has been repeatedly reported. The resistance substitutions I223V and S247N, alone or in combination with the major oseltamivir-resistance mutation H275Y, have been observed in 2009 pandemic H1N1 viruses. We overexpressed and purified the ectodomain of wild-type neuraminidase from the A/California/07/2009 (H1N1) influenza virus, as well as variants containing H275Y, I223V, and S247N single mutations and H275Y/I223V and H275Y/S247N double mutations. We performed enzymological and thermodynamic analyses and structurally examined the resistance mechanism. Our results reveal that the I223V or S247N substitution alone confers only a moderate reduction in oseltamivir affinity. In contrast, the major oseltamivir resistance mutation H275Y causes a significant decrease in the enzyme’s ability to bind this drug. Combination of H275Y with an I223V or S247N mutation results in extreme impairment of oseltamivir’s inhibition potency. Our structural analyses revealed that the H275Y substitution has a major effect on the oseltamivir binding pose within the active site while the influence of other studied mutations is much less prominent. Our crystal structures also helped explain the augmenting effect on resistance of combining H275Y with both substitutions.
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a antivirové látky $x farmakologie $7 D000998
650    _2
$a kalorimetrie $7 D002151
650    _2
$a krystalizace $7 D003460
650    _2
$a virová léková rezistence $x genetika $7 D024882
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a lidé $7 D006801
650    _2
$a virus chřipky A, podtyp H1N1 $x účinky léků $x enzymologie $x genetika $7 D053118
650    _2
$a chřipka lidská $x virologie $7 D007251
650    _2
$a kinetika $7 D007700
650    _2
$a missense mutace $7 D020125
650    _2
$a neuraminidasa $x chemie $x genetika $7 D009439
650    _2
$a oseltamivir $x farmakologie $7 D053139
650    _2
$a termodynamika $7 D013816
650    _2
$a virové proteiny $x chemie $x genetika $7 D014764
650    _2
$a replikace viru $7 D014779
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pachl, Petr $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. petr.pachl@uochb.cas.cz.
700    1_
$a Karlukova, Elena $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. karlukova@email.cz. Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic. karlukova@email.cz.
700    1_
$a Hejdánek, Jakub $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jakub.hejdanek@uochb.cas.cz. Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. jakub.hejdanek@uochb.cas.cz.
700    1_
$a Řezáčová, Pavlína $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. pavlina.rezacova@uochb.cas.cz. The Czech Academy of Sciences, Institute of Molecular Genetics, Vídeňská 1083, 140 00 Prague 4, Czech Republic. pavlina.rezacova@uochb.cas.cz.
700    1_
$a Machara, Aleš $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. ales.machara@uochb.cas.cz. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. ales.machara@uochb.cas.cz.
700    1_
$a Hudlický, Jason $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. j.r.hudlicky@gmail.com. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. j.r.hudlicky@gmail.com.
700    1_
$a Konvalinka, Jan $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jan.konvalinka@uochb.cas.cz. Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. jan.konvalinka@uochb.cas.cz.
700    1_
$a Kožíšek, Milan $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. milan.kozisek@uochb.cas.cz.
773    0_
$w MED00177099 $t Viruses $x 1999-4915 $g Roč. 10, č. 7 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29933553 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190408082229 $b ABA008
999    __
$a ok $b bmc $g 1391905 $s 1050900
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 10 $c 7 $e 20180621 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...